Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial
Christopher J. Sweeney(Centre for Cancer Biology), Andrew Martin(The University of Sydney), Martin R. Stockler(The University of Sydney), Stephen Begbie(Port Macquarie Base Hospital), Leanna Cheung(The University of Sydney), Kim N.(University of British Columbia), Simon Chowdhury(Sarah Cannon Research Institute), Mark Frydenberg(Monash University), Lisa G. Horvath(The University of Sydney), Anthony M. Joshua(Garvan Institute of Medical Research), Nicola Jane Lawrence(University of Auckland), Gavin Marx(Australian National University), John McCaffrey(Mater Misericordiae University Hospital), Ray McDermott(University College Dublin), Margaret McJannett(Australian and New Zealand Urogenital and Prostate Cancer Trials Group), Scott North(University of Alberta), Francis Parnis(The University of Adelaide), Wendy R. Parulekar(Queen's University), David Pook(Monash Health), M. Neil Reaume(University of Ottawa), Shahneen Sandhu(The University of Melbourne), Alvin Tan(Waikato Regional Council), Thean Hsiang Tan(Royal Adelaide Hospital), Alastair Thomson(Royal Cornwall Hospital), Francisco Vera-Badillo(Queen's University), Scott Williams(The University of Melbourne), Diana Winter(The University of Sydney), Sonia Yip(The University of Sydney), Alison Y. Zhang(The University of Sydney), Robert Zielinski(Western NSW Local Health District), Ian D. Davis(Eastern Health), Ehtesham Abdi, Suzanne Allan, Patricia Bastick, Stephen Begbie(Port Macquarie Base Hospital), Robert Blum(Western NSW Local Health District), Karen Briscoe, Daniel Brungs, Sean Bydder, Bala Renuka Chittajallu, Michelle R. Cronk, Katharine Cuff, Ian D. Davis(Eastern Health), Anthony Dowling(Garvan Institute of Medical Research), Mark Frydenberg(Monash University), M. C. George, Lisa G. Horvath(The University of Sydney), Elizabeth Hovey, Anthony M. Joshua(Garvan Institute of Medical Research), Narayan Karanth, Ganessan Kichenadasse, Laurence E. Krieger, Gavin Marx(Australian National University), Maitham Mathlum, Louise Nott, Zulfiquer Otty, Francis Parnis(The University of Adelaide), David Pook(Monash Health), Shahneen Sandhu(The University of Melbourne), Sanjeev Sewak, Amanda Gwendolyn Stevanovic, Martin R. Stockler(The University of Sydney), Aneta Suder, Hsiang Tan(Royal Adelaide Hospital), Javier Torres, Simon Troon(Sarah Cannon Research Institute), Craig Underhill, Andrew Weickhardt(The University of Sydney), Robert Zielinski(Western NSW Local Health District), Tahir Abbas, Ghadeer Anan, Chris Booth(Centre for Cancer Biology), H. E. A. Campbell, Kim Chi(University of British Columbia), Joseph L. Chin, E. Chouinard, Bryan Donnelly, Darrel Drachenberg, Amir Faghih, Antonio Finelli, Sebastién J. Hotte, Krista Noonan, Scott North(University of Alberta), Mohammad Rassouli, Neil Reaume(University of Ottawa), Ricardo Rendon, Fred Saad, Evgeny Sadikov, Éric Vigneault, Paweł Zalewski, John McCaffrey(Mater Misericordiae University Hospital), Ray McDermott(University College Dublin), Patrick G. Morris, Miriam O’Connor, Paul Donnellan, Dearbhaile M. O’Donnell, Jim Edwards, Peter C.C. Fong, Alvin Tan(Waikato Regional Council), Simon Chowdhury(Sarah Cannon Research Institute), Simon J. Crabb(Sarah Cannon Research Institute), Omar Khan, Vincent Khoo, Graham Macdonald, Heather Payne, Angus Robinson, Jonathon Shamash, John Staffurth(Mater Misericordiae University Hospital), Carys Thomas, Alastair Thomson(Royal Cornwall Hospital), Christopher J. Sweeney(Centre for Cancer Biology)
Cited by 184
Abstract
Related Papers
No related papers found
Powered by citation graph analysis